Precigen PGEN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.48M-75.3% | $30.23M+111% | $14.32M+4.1% | $13.76M+127% | $6.06M-79.5% | ||
| $48.77M-27.9% | $67.62M-36.7% | $106.81M+132% | $45.99M-38.0% | $74.18M+8.5% | ||
| $26.4M+574% | $3.92M+575% | $580K+77.4% | $327K-56.5% | $751K-18.9% | ||
| —— | —— | —— | —— | —— | ||
| $101.67M-11.8% | $115.24M-11.1% | $129.6M+107% | $62.76M-25.8% | $84.6M-17.4% | ||
| $13.22M-3.9% | $13.76M-7.1% | $14.81M+0.8% | $14.7M+0.2% | $14.67M+6.1% | ||
| $15.23M0.0% | $15.23M0.0% | $15.23M0.0% | $15.23M-20.4% | $19.14M0.0% | ||
| $2.86M-10.0% | $3.18M-9.1% | $3.5M-8.3% | $3.82M-7.7% | $4.14M-7.2% | ||
| $138.63M-10.9% | $155.51M-9.2% | $171.26M+68.1% | $101.9M-20.9% | $128.79M-11.3% | ||
| $410K-20.7% | $517K+7.7% | $480K+16.2% | $413K-24.8% | $549K-6.8% | ||
| $21.1M-43.4% | $37.31M+16.3% | $32.07M+38.3% | $23.19M-3.3% | $23.99M+11.5% | ||
| —— | —— | —— | —— | —— | ||
| $118.39M-12.0% | $134.59M+4.0% | $129.4M+64.7% | $78.56M-5.4% | $83.02M+64.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$2.35B-0.3% | -$2.34B-1.0% | -$2.32B-6.7% | -$2.17B-1.2% | -$2.14B-2.6% | ||
| $20.24M-3.2% | $20.91M-50.1% | $41.87M+214% | -$36.78M-162% | -$14.06M-137% | ||
| $138.63M-10.9% | $155.51M-9.2% | $171.26M+68.1% | $101.9M-20.9% | $128.79M-11.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Precigen cover its short-term obligations?
- Its current ratio is 4.82 — current assets exceed current liabilities.
- Where does Precigen's balance sheet data come from?
- Every line is extracted from Precigen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.